Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.710
-0.270 (-9.06%)
At close: Dec 20, 2024, 4:00 PM
2.660
-0.050 (-1.85%)
After-hours: Dec 20, 2024, 4:30 PM EST
Daré Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 11.23 | 10.48 | 34.67 | 51.67 | 4.67 | 4.78 | Upgrade
|
| Cash & Short-Term Investments | 11.23 | 10.48 | 34.67 | 51.67 | 4.67 | 4.78 | Upgrade
|
| Cash Growth | -19.16% | -69.78% | -32.91% | 1006.64% | -2.31% | -29.77% | Upgrade
|
| Other Receivables | 0.52 | 0.95 | 1.7 | 1.15 | 0.46 | 0.56 | Upgrade
|
| Receivables | 0.52 | 0.95 | 1.7 | 1.15 | 0.46 | 0.56 | Upgrade
|
| Prepaid Expenses | 3.19 | 6.12 | 6.67 | 2.48 | 1.85 | 1.11 | Upgrade
|
| Total Current Assets | 14.95 | 17.54 | 43.04 | 55.3 | 6.98 | 6.44 | Upgrade
|
| Property, Plant & Equipment | 2.03 | 1.98 | 0.52 | 0.24 | 0.28 | 0.55 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.14 | - | - | Upgrade
|
| Other Long-Term Assets | 1.08 | 1.76 | 0.26 | 0.13 | 0.29 | 0.45 | Upgrade
|
| Total Assets | 18.06 | 21.28 | 43.83 | 55.81 | 7.55 | 7.44 | Upgrade
|
| Accounts Payable | 1.05 | 3.39 | 2.03 | 2.1 | 1.02 | 1.08 | Upgrade
|
| Accrued Expenses | 1.85 | 2.89 | 10.89 | 3.14 | 3.36 | 2.1 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.37 | - | Upgrade
|
| Current Portion of Leases | 0.51 | 0.47 | 0.4 | 0.27 | 0.35 | 0.41 | Upgrade
|
| Current Unearned Revenue | 9.75 | 13.74 | 18.3 | 10.54 | 1.56 | 2.02 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 1 | - | Upgrade
|
| Total Current Liabilities | 13.16 | 20.48 | 31.62 | 16.05 | 7.66 | 5.61 | Upgrade
|
| Long-Term Leases | 0.9 | 0.94 | 0.09 | - | 0.04 | 0.39 | Upgrade
|
| Long-Term Unearned Revenue | 1 | 4.91 | 1 | 1 | 1 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 1 | Upgrade
|
| Total Liabilities | 19.54 | 26.33 | 32.71 | 17.05 | 8.7 | 7 | Upgrade
|
| Common Stock | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 168.66 | 166.54 | 152.53 | 149.03 | 70.37 | 44.56 | Upgrade
|
| Retained Earnings | -169.78 | -171.24 | -141.07 | -110.13 | -71.43 | -44.02 | Upgrade
|
| Comprehensive Income & Other | -0.36 | -0.36 | -0.35 | -0.15 | -0.09 | -0.1 | Upgrade
|
| Shareholders' Equity | -1.48 | -5.05 | 11.11 | 38.75 | -1.15 | 0.44 | Upgrade
|
| Total Liabilities & Equity | 18.06 | 21.28 | 43.83 | 55.81 | 7.55 | 7.44 | Upgrade
|
| Total Debt | 5.89 | 1.4 | 0.49 | 0.27 | 0.76 | 0.8 | Upgrade
|
| Net Cash (Debt) | 5.34 | 9.07 | 34.18 | 51.4 | 3.91 | 3.98 | Upgrade
|
| Net Cash Growth | -61.03% | -73.46% | -33.50% | 1213.79% | -1.68% | -41.53% | Upgrade
|
| Net Cash Per Share | 0.64 | 1.25 | 4.85 | 10.09 | 1.56 | 3.07 | Upgrade
|
| Filing Date Shares Outstanding | 8.7 | 8.38 | 7.18 | 7 | 3.94 | 2.06 | Upgrade
|
| Total Common Shares Outstanding | 8.55 | 8.33 | 7.07 | 7 | 3.47 | 1.64 | Upgrade
|
| Working Capital | 1.79 | -2.94 | 11.41 | 39.24 | -0.68 | 0.83 | Upgrade
|
| Book Value Per Share | -0.17 | -0.61 | 1.57 | 5.54 | -0.33 | 0.27 | Upgrade
|
| Tangible Book Value | -1.48 | -5.05 | 11.11 | 38.75 | -1.15 | 0.44 | Upgrade
|
| Tangible Book Value Per Share | -0.17 | -0.61 | 1.57 | 5.54 | -0.33 | 0.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.